0
Skip to Content
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
Home
Folder: About ⌄
Back
About
Members
Meet the Team
Folder: Learn ⌄
Back
Why
FAQs
Folder: Governance ⌄
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group ⌄
Back
About
Members
Events
Folder: Latest ⌄
Back
News
Events
Videos
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Embedded Video Item Thumbnail PSYCH Symposium: The Future of Psychedelic Medicine in the EU
Related Embedded Video Item Thumbnail Psychedelic-assisted therapies in the treatment of brain disorders - European Parliament
Related Embedded Video Item Thumbnail SA TAIP seminar: 14.01.25 Tadeusz Hawrot
Related Embedded Video Item Thumbnail Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023
Related Embedded Video Item Thumbnail PAREA: psychedelic-assisted therapies in Europe
Download Leading Not Lagging Policy Paper

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy